80064693 - 24th Annual Current Topics in Gastrointestinal and Liver Pathology

Saturday, October 26, 2024, 7:50 AM - Sunday, October 27, 2024, 6:45 PM, Online


This 24th annual conference is intended as a practical overview for pathologists who encounter gastrointestinal, liver, and pancreatobiliary specimens in daily practice. Interpretation of biopsy and resection specimens will be addressed, as well as recent advances in ancillary testing and molecular diagnostics. Case presentations will be featured to apply presented concepts. Participants should come away with a better understanding of the diagnostic approach to non-neoplastic and neoplastic specimens and the application of modern molecular techniques.

1. Discuss the targeted therapies currently available for upper gastrointestinal malignancies.
2. Describe the biomarkers evaluated in colorectal carcinoma in routine clinical practice.
3. List the molecular biomarkers that are used in clinical liver tumor pathology practice.
4. Discuss emerging risk stratification methods in Barrett esophagus.
5. Discuss important criteria for risk stratification in patients with locally resected invasive colorectal adenocarcinoma.
6. Consider the differences in gastric neuroendocrine neoplasms versus those in the small intestine, pancreas, colon, and anus.
7. Describe GI pathology-specific applications of artificial intelligence.
8. List the differential diagnosis for the most commonly encountered patterns of colitis.
9. Discuss the differential diagnosis for the most common infectious organisms that affect the GI tract.
10. Discuss the diagnostic workup for Hirschsprung’s disease.
11. Review common issues in autoimmune hepatitis.
12. Assess the utility of routine, special and immunohistochemical stains in constructing a final diagnosis for a liver mass directed biopsy.
13. Describe the approach to sampling margins and lesional tissue in pancreatic resections.
14. Recognize the major cystic neoplasms of the pancreas.

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Other Credits
This activity has been registered to offer credit in the American Board of Pathology (ABPath) Maintenance of Certification program for Lifelong Learning (CME) for up to 16.75 credits.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.